Caruso ML - Search Results

1

Tumor microenvironment immune types in gastric cancer are associated with mismatch repair however, not HER2 status.

Valentini AM, Di Pinto F, Coletta S, Guerra V, Armentano R, Caruso ML. Valentini AM, et al. Among authors: caruso ml. Oncol Lett. 2019 Aug;18(2):1775-1785. doi: 10.3892/ol.2019.10513. Epub 2019 Jun 21. Oncol Lett. 2019. PMID: 31423245 Free PMC article.

2

Chemotherapeutic agents for colorectal cancer with a defective mismatch repair system: the state of the art.

Valentini AM, Armentano R, Pirrelli M, Caruso ML. Valentini AM, et al. Among authors: caruso ml. Cancer Treat Rev. 2006 Dec;32(8):607-18. doi: 10.1016/j.ctrv.2006.08.001. Epub 2006 Oct 18. Cancer Treat Rev. 2006. PMID: 17055172 Review.

3

RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision Medicine.

Valentini AM, Cavalcanti E, Di Maggio M, Caruso ML. Valentini AM, et al. Among authors: caruso ml. Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):539-544. doi: 10.1097/PAI.0000000000000475. Appl Immunohistochem Mol Morphol. 2018. PMID: 30199395 Free PMC article.

4

Mismatch repair, p53 and beta-catenin proteins in colorectal cancer.

Valentini AM, Renna L, Armentano R, Pirrelli M, Di Leo A, Gentile M, Caruso ML. Valentini AM, et al. Among authors: caruso ml. Anticancer Res. 2002 Jul-Aug;22(4):2083-8. Anticancer Res. 2002. PMID: 12174887

5

Immunohistochemical mismatch repair proteins expression in colorectal cancer.

Valentini AM, Armentano R, Pirrelli M, Gentile M, Caruso ML. Valentini AM, et al. Among authors: caruso ml. Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):42-5. doi: 10.1097/01.pai.0000155193.92167.6a. Appl Immunohistochem Mol Morphol. 2006. PMID: 16540729

6

EGFR-targeted therapy in colorectal cancer: does immunohistochemistry deserve a role in predicting the response to cetuximab?

Valentini AM, Pirrelli M, Caruso ML. Valentini AM, et al. Among authors: caruso ml. Curr Opin Mol Ther. 2008 Apr;10(2):124-31. Curr Opin Mol Ther. 2008. PMID: 18386224 Review.

7

Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.

Cavalcanti E, Armentano R, Valentini AM, Chieppa M, Caruso ML. Cavalcanti E, et al. Among authors: caruso ml. Cell Death Dis. 2017 Aug 24;8(8):e3004. doi: 10.1038/cddis.2017.401. Cell Death Dis. 2017. PMID: 28837143 Free PMC article.

8

PD-L1 expression in colorectal cancer defines three subsets of tumor immune microenvironments.

Valentini AM, Di Pinto F, Cariola F, Guerra V, Giannelli G, Caruso ML, Pirrelli M. Valentini AM, et al. Among authors: caruso ml. Oncotarget. 2018 Jan 12;9(9):8584-8596. doi: 10.18632/oncotarget.24196. eCollection 2018 Feb 2. Oncotarget. 2018. PMID: 29492219 Free PMC article.

9

Increased nerve twigs in small intestinal mucosa with programmed cell death-ligand 1 and somatostatin receptor type 2A expression in recurrent Crohn disease: A case report.

Caruso ML, Di Pinto F, Ignazzi A, Coletta S, Valentini AM, Cavalcanti E, De Michele F. Caruso ML, et al. Medicine (Baltimore). 2018 Dec;97(49):e13492. doi: 10.1097/MD.0000000000013492. Medicine (Baltimore). 2018. PMID: 30544444 Free PMC article.

10

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

Pirrelli M, Caruso ML, Di Maggio M, Armentano R, Valentini AM. Pirrelli M, et al. Among authors: caruso ml. Dig Dis Sci. 2013 Feb;58(2):397-404. doi: 10.1007/s10620-012-2357-3. Epub 2012 Aug 24. Dig Dis Sci. 2013. PMID: 22918687 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters